IART FY 2018 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena

IARTIntegra LifeSciences Holdings Corporation

$747M

FY 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$1.5B+23.9% YoY

Gross Profit

$901M61.2% margin

Operating Income

$111M7.5% margin

Net Income

$61M4.1% margin

EPS (Diluted)

$0.72

Cash Flow

Operating Cash Flow

$200M

Free Cash Flow

$122M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$3.1B

Total Liabilities

$1.7B

Stockholders' Equity

$1.4B

Cash & Equivalents

$139M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.5B	$1.2B	+23.9%
Gross Profit	$901M	$753M	+19.7%
Operating Income	$111M	$45M	+147.7%
Net Income	$61M	$65M	-6.1%